Zoetis Inc. Share Price

Equities

ZTS

US98978V1035

Pharmaceuticals

Market Closed - Nyse 01:30:02 01/06/2024 am IST 5-day change 1st Jan Change
169.6 USD +0.07% Intraday chart for Zoetis Inc. -0.30% -14.09%
Sales 2024 * 9.15B 763B Sales 2025 * 9.77B 815B Capitalization 77.37B 6,454B
Net income 2024 * 2.51B 209B Net income 2025 * 2.76B 230B EV / Sales 2024 * 8.91 x
Net Debt 2024 * 4.18B 348B Net Debt 2025 * 3.49B 291B EV / Sales 2025 * 8.28 x
P/E ratio 2024 *
31 x
P/E ratio 2025 *
28.1 x
Employees 14,100
Yield 2024 *
1.02%
Yield 2025 *
1.16%
Free-Float 90.81%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.07%
1 week-0.30%
1 month+1.39%
3 months-11.14%
6 months-5.34%
Current year-14.09%
More quotes
1 week
167.96
Extreme 167.955
174.17
1 month
161.00
Extreme 161
175.78
Current year
144.80
Extreme 144.8
200.53
1 year
144.80
Extreme 144.8
201.92
3 years
124.15
Extreme 124.1483
249.27
5 years
90.14
Extreme 90.14
249.27
10 years
31.13
Extreme 31.13
249.27
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 01/12/01
Director of Finance/CFO 52 01/21/01
Chief Tech/Sci/R&D Officer - 01/11/01
Members of the board TitleAgeSince
Chairman 71 01/13/01
Director/Board Member 73 01/13/01
Director/Board Member 74 01/13/01
More insiders
Date Price Change Volume
31/24/31 169.6 +0.07% 4,088,435
30/24/30 169.4 -0.80% 2,904,697
29/24/29 170.8 -0.29% 3,071,529
28/24/28 171.3 +0.72% 2,304,376

Delayed Quote Nyse, May 01, 2024 at 01:30 am IST

More quotes
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
169.6 USD
Average target price
211.2 USD
Spread / Average Target
+24.56%
Consensus